These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26169501)

  • 1. Factors associated with steatosis in liver biopsies of individuals with chronic hepatitis C infection in southern Brazil.
    Giustina RD; Marconcini ML; Bansho ET; Tonon D; Pasinato AP; Dantas-Corrêa EB; Schiavon LL; Narciso-Schiavon JL
    Arab J Gastroenterol; 2015 Jun; 16(2):59-62. PubMed ID: 26169501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.
    Tachi Y; Katano Y; Honda T; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Samejima Y; Goto H
    Liver Int; 2010 Apr; 30(4):554-9. PubMed ID: 19951380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation.
    Hwang SJ; Luo JC; Chu CW; Lai CR; Lu CL; Tsay SH; Wu JC; Chang FY; Lee SD
    J Gastroenterol Hepatol; 2001 Feb; 16(2):190-5. PubMed ID: 11207900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Steatosis in chronic hepatitis C: prevalence and predictive factors].
    Ouakaa-Kchaou A; Gargouri D; Kochlef A; Debbiche A; Elloumi H; Ghouma M; Kilani A; Romani M; Kharrat J; Ghorbel A
    Tunis Med; 2011 Nov; 89(11):830-6. PubMed ID: 22179918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters.
    Rastogi A; Sakhuja P; Kumar A; Hissar S; Jain A; Gondal R; Sarin SK
    Indian J Pathol Microbiol; 2011; 54(3):454-9. PubMed ID: 21934202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic steatosis in Iranian patients with chronic hepatitis C.
    Minakari M; Sameni FK; Shalmani HM; Molaee M; Zali MR
    Med Princ Pract; 2008; 17(2):126-30. PubMed ID: 18287796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron and proinflammatory cytokines in chronic hepatitis C virus infection.
    López-Prieto J; González-Reimers E; Alemán-Valls MR; de la Vega-Prieto MJ; Abreu-González P; Pelazas-González R; Hernández-Luis R; Jorge-Ripper C; Santolaria-Fernández F
    Biol Trace Elem Res; 2013 Oct; 155(1):5-10. PubMed ID: 23892696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steatosis and bile duct damage in chronic hepatitis C: distribution and relationships in a group of Northern Italian patients.
    Giannini E; Ceppa P; Botta F; Fasoli A; Romagnoli P; Cresta E; Venturino V; Risso D; Celle G; Testa R
    Liver; 1999 Oct; 19(5):432-7. PubMed ID: 10533803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.
    Antúnez I; Aponte N; Fernández-Carbia A; Rodríguez-Perez F; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):57-60. PubMed ID: 16929588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
    Sanyal AJ; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Stravitz RT; Mills AS
    Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
    Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
    J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FREQUENCY AND SEVERITY OF STEATOSIS IN PATIENTS WITH CHRONIC HEPATITIS-C.
    Khan AN; Said K; Ali K; Gul R
    J Ayub Med Coll Abbottabad; 2015; 27(1):105-7. PubMed ID: 26182751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus.
    Marks KM; Petrovic LM; Talal AH; Murray MP; Gulick RM; Glesby MJ
    J Infect Dis; 2005 Dec; 192(11):1943-9. PubMed ID: 16267765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver steatosis in children with chronic hepatitis C.
    Guido M; Bortolotti F; Jara P; Giacomelli L; Fassan M; Hierro L; Nebbia G; Zancan L; Rugge M
    Am J Gastroenterol; 2006 Nov; 101(11):2611-5. PubMed ID: 17090284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic steatosis and fibrosis in chronic hepatitis C in Taiwan.
    Hsieh MH; Lee LP; Hsieh MY; Tsai KB; Huang JF; Hou NJ; Chen SC; Lin ZY; Hsieh MY; Wang LY; Dai CY; Chuang WL; Yu ML
    Jpn J Infect Dis; 2007 Nov; 60(6):377-81. PubMed ID: 18032828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.
    Yun JW; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
    Liver Int; 2009 Jul; 29(6):878-83. PubMed ID: 19192167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steatosis in chronic hepatitis C: relationship to the virus and host risk factors.
    Matos CA; Perez RM; Pacheco MS; Figueiredo-Mendes CG; Lopes-Neto E; Oliveira EB; Lanzoni VP; Silva AE; Ferraz ML
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1236-9. PubMed ID: 16872303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.
    Giannini E; Ceppa P; Botta F; Mastracci L; Romagnoli P; Comino I; Pasini A; Risso D; Lantieri PB; Icardi G; Barreca T; Testa R
    Am J Gastroenterol; 2000 Nov; 95(11):3211-7. PubMed ID: 11095344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
    Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
    Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
    Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.